Magellan Rx Management Revenue and Competitors
Estimated Revenue & Valuation
- Magellan Rx Management's estimated annual revenue is currently $173.8M per year.
- Magellan Rx Management's estimated revenue per employee is $823,756
Employee Data
- Magellan Rx Management has 211 Employees.
- Magellan Rx Management grew their employee count by -47% last year.
Magellan Rx Management's People
Name | Title | Email/Phone |
---|---|---|
1 | Account Director, Payor Access | Reveal Email/Phone |
Magellan Rx Management Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.1M | 19 | -10% | N/A | N/A |
#2 | $8.9M | 35 | 9% | N/A | N/A |
#3 | $13.9M | 33 | -25% | N/A | N/A |
#4 | $9.9M | 72 | 16% | N/A | N/A |
#5 | $59.1M | 199 | 7% | N/A | N/A |
#6 | $9.3M | 32 | -3% | N/A | N/A |
#7 | $10.4M | 48 | 41% | N/A | N/A |
#8 | $15.8M | 51 | 2% | N/A | N/A |
#9 | $9.5M | 48 | 41% | N/A | N/A |
#10 | $4.7M | 19 | 0% | N/A | N/A |
What Is Magellan Rx Management?
We specialize in solving complex pharmacy challenges for our customers. We believe in developing smart solutions that leverage our industry-leading experience and technology to exceed expectations.
keywords:N/AN/A
Total Funding
211
Number of Employees
$173.8M
Revenue (est)
-47%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Magellan Rx Management News
2022-04-19 - Capital Rx Names Pharmacy Benefits Veteran Philip Vecchiolli as SVP and
General Manager of Pharmacy Benefit Administration Services
Vecchiolli also had senior sales roles at Magellan Rx, Aetna Pharmacy Management, Convey Health, and NovoLogix.
2022-03-22 - Digital Therapeutics Hold Promise for Behavioral Health
... cover digital therapeutic products, said Soumya Vishwanath, PharmD, the senior manager of formulary strategy for Magellan Rx Management.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $34M | 211 | 3% | N/A |
#2 | $39.4M | 212 | -2% | N/A |
#3 | $7.5M | 214 | 13% | N/A |
#4 | $49.4M | 214 | N/A | N/A |
#5 | $54.3M | 217 | 3% | N/A |